Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07294092) titled 'Ketamine and Propofol NeuroImaging' on Dec. 16, 2025.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Basic Science. Masking: None (Open Label).
Primary Sponsor: Keith M Vogt
Condition:
Anesthesia
Pain
Intervention:
Drug: Propofol
Drug: Ketamine
Recruitment Status: Recruiting
Phase: Early Phase 1
Date of First Enrollment: March 1, 2026
Target Sample Size: 60
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07294092
Disclaimer: Curated by HT Syndication....